Assays for Qualification and Quality Stratification of Clinical Biospecimens Used in Research: A Technical Report from the ISBER Biospecimen Science Working Group

This technical report presents quality control (QC) assays that can be performed in order to qualify clinical biospecimens that have been biobanked for use in research. Some QC assays are specific to a disease area. Some QC assays are specific to a particular downstream analytical platform. When such a qualification is not possible, QC assays are presented that can be performed to stratify clinical biospecimens according to their biomolecular quality.

[1]  F. Betsou,et al.  Long-term stability of coagulation variables: Protein S as a biomarker for preanalytical storage-related variations in human plasma , 2009, Thrombosis and Haemostasis.

[2]  E. Bosmans,et al.  The effects of anticoagulation and processing on assays of IL-6, sIL-6R, sIL-2R and soluble transferrin receptor. , 1997, Cytokine.

[3]  R. Dodd,et al.  Stability of serum alanine aminotransferase activity , 1987, Transfusion.

[4]  H. Drexler,et al.  Authentication of scientific human cell lines: easy-to-use DNA fingerprinting. , 2005, Methods in molecular biology.

[5]  A. Gotoh,et al.  Measurement of cystatin-C and creatinine in urine. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[6]  Erik Peter,et al.  Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling. , 2014, Clinical chemistry.

[7]  M. Keeney,et al.  User‐defined protein marker assay development for characterization of circulating tumor cells using the CellSearch® system , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[8]  Michael Q. Zhang,et al.  An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia , 2009, Nucleic acids research.

[9]  Tania Nolan,et al.  SPUD: a quantitative PCR assay for the detection of inhibitors in nucleic acid preparations. , 2006, Analytical biochemistry.

[10]  N. Heegaard,et al.  Characterization and stability of transthyretin isoforms in cerebrospinal fluid examined by immunoprecipitation and high-resolution mass spectrometry of intact protein. , 2012, Methods.

[11]  P. Svenningsson,et al.  The significance of biochemical and molecular sample integrity in brain proteomics and peptidomics: Stathmin 2‐20 and peptides as sample quality indicators , 2007, Proteomics.

[12]  M. Loda,et al.  DNA degradation test predicts success in whole-genome amplification from diverse clinical samples. , 2007, The Journal of molecular diagnostics : JMD.

[13]  A. Vortmeyer,et al.  Intrinsic indicators for specimen degradation , 2013, Laboratory Investigation.

[14]  M. Werner,et al.  Influence of Fixation, Antibody Clones, and Signal Amplification on Steroid Receptor Analysis , 1998 .

[15]  A. Wu,et al.  The effect of class-specific protease inhibitors on the stabilization of B-type natriuretic peptide in human plasma. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[16]  I. Bjarnason,et al.  Fecal calprotectin as an index of intestinal inflammation. , 2001, Drugs of today.

[17]  Robert M Califf,et al.  Evolution of adverse changes in stored RBCs , 2007, Proceedings of the National Academy of Sciences.

[18]  P. Nederlof,et al.  A multiplex PCR predictor for aCGH success of FFPE samples , 2005, British Journal of Cancer.

[19]  R. Bilonick,et al.  Delayed processing of blood increases the frequency of activated CD11b+ CD15+ granulocytes which inhibit T cell function. , 2009, Journal of immunological methods.

[20]  M. Dowsett,et al.  Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer , 2010, Breast Cancer Research.

[21]  Forest M White,et al.  Phosphotyrosine signaling analysis in human tumors is confounded by systemic ischemia-driven artifacts and intra-specimen heterogeneity. , 2015, Cancer research.

[22]  R. Aebersold,et al.  Direct analytical sample quality assessment for biomarker investigation: Qualifying cerebrospinal fluid samples , 2014, Proteomics.

[23]  F. Maquart,et al.  Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice , 2005, Clinical chemistry and laboratory medicine.

[24]  Umberto Nanni,et al.  Standard preanalytical coding for biospecimens: review and implementation of the Sample PREanalytical Code (SPREC). , 2012, Biopreservation and biobanking.

[25]  Wilhelm G. Dirks,et al.  Authentication of scientific human cell lines: easy-to-use DNA fingerprinting. , 2005, Methods in molecular biology.

[26]  Pierre Lescuyer,et al.  LacaScore: a novel plasma sample quality control tool based on ascorbic acid and lactic acid levels , 2016, Metabolomics.

[27]  T. Kubiak,et al.  Direct Quantification of Cell-Free, Circulating DNA from Unpurified Plasma , 2014, PloS one.

[28]  C. Gelfand,et al.  Inhibition of intrinsic proteolytic activities moderates preanalytical variability and instability of human plasma. , 2007, Journal of proteome research.

[29]  J. Egan,et al.  The Role of Incretins in Glucose Homeostasis and Diabetes Treatment , 2008, Pharmacological Reviews.

[30]  Rohit Bhargava,et al.  The effect of cold ischemic time on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast carcinoma , 2012, Modern Pathology.

[31]  Weimin Zhu,et al.  Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. , 2003, Journal of proteome research.

[32]  D. Evenson,et al.  Sperm chromatin structure assay is useful for fertility assessment. , 2000, Methods in cell science : an official journal of the Society for In Vitro Biology.

[33]  F. Speleman,et al.  Measurable impact of RNA quality on gene expression results from quantitative PCR , 2011, Nucleic acids research.

[34]  S. Holme,et al.  The expression of p‐selectin during collection, processing, and storage of platelet concentrates: relationship to loss of in vivo viability , 1997, Transfusion.

[35]  L. Qiu,et al.  Multicenter evaluation of a new progastrin-releasing peptide (ProGRP) immunoassay across Europe and China. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[36]  Yuval Kluger,et al.  A Tissue Quality Index – an Intrinsic Control for Measurement of Effects of Pre-analytical Variables on FFPE Tissue , 2014, Laboratory Investigation.

[37]  Anders Wallin,et al.  Cystatin C in cerebrospinal fluid and multiple sclerosis , 2007, Annals of neurology.

[38]  Thomas Burke,et al.  Human Biospecimen Research: Experimental Protocol and Quality Control Tools , 2009, Cancer Epidemiology Biomarkers & Prevention.

[39]  F. Betsou,et al.  Soluble CD40 ligand as a biomarker for storage-related preanalytic variations of human serum. , 2008, Cytokine.

[40]  H. Budka,et al.  Brain Protein Preservation Largely Depends on the Postmortem Storage Temperature: Implications for Study of Proteins in Human Neurologic Diseases and Management of Brain Banks: A BrainNet Europe Study , 2007, Journal of neuropathology and experimental neurology.

[41]  Takashi Nakajima,et al.  The efficacy of uracil DNA glycosylase pretreatment in amplicon-based massively parallel sequencing with DNA extracted from archived formalin-fixed paraffin-embedded esophageal cancer tissues. , 2015, Cancer genetics.

[42]  B. Chong,et al.  Plasma P-selectin is increased in thrombotic consumptive platelet disorders. , 1994, Blood.

[43]  K. Kultima,et al.  Impact of Temperature Dependent Sampling Procedures in Proteomics and Peptidomics – A Characterization of the Liver and Pancreas Post Mortem Degradome , 2010, Molecular & Cellular Proteomics.

[44]  J Cummings,et al.  Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs , 2010, British Journal of Cancer.

[45]  M. Blombäck,et al.  Improvement of Plasma Quality as Raw Material for Factor VIII:C Concentrates , 1983, Vox sanguinis.

[46]  T. Grimsrud,et al.  Stability of selected serum proteins after long-term storage in the Janus Serum Bank , 2009, Clinical chemistry and laboratory medicine.

[47]  M. Hellmich,et al.  Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types , 2004, The Pharmacogenomics Journal.

[48]  B. Han,et al.  Sustained viral activity of epstein-Barr virus contributes to cellular immortalization of lymphoblastoid cell lines , 2009, Molecules and cells.

[49]  D. Kristoffersen,et al.  Reference range of some enzymes and proteins in untimed overnight urine and their stability after freezing. , 1998, Clinica chimica acta; international journal of clinical chemistry.